<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(18)</volume><submitter>Wu ZL</submitter><pubmed_abstract>Eleven undescribed &lt;i>ent&lt;/i>-kaurane-type diterpenoid acids, namely noueinsiancins A-K (1-11), together with sixteen related known analogs (12-27) were isolated from &lt;i>Nouelia insignis&lt;/i> Franch. The chemical structures and absolute configurations of the new compounds were confirmed by the extensive spectroscopic data, electronic circular dichroism (ECD) data analysis and single crystal X-ray diffraction. Additionally, the anti-inflammatory assay was applied to estimate the nitric oxide (NO) inhibitory activities of all compounds by using lipopolysaccharide (LPS)-induced RAW 264.7 cells &lt;i>in vitro&lt;/i>. The results revealed that 4-7 and 13-17 significantly inhibited NO production at the concentrations of 2.5 μM, 5.0 μM and 10.0 μM. Meanwhile, compounds 6 and 7 were found to down-regulat</pubmed_abstract><journal>RSC advances</journal><pagination>11155-11163</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8995843</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>New &lt;i>ent&lt;/i>-kaurane diterpenoid acids from &lt;i>Nouelia insignis&lt;/i> Franch and their anti-inflammatory activity.</pubmed_title><pmcid>PMC8995843</pmcid><pubmed_authors>Zhang WD</pubmed_authors><pubmed_authors>Sun ZS</pubmed_authors><pubmed_authors>Li HL</pubmed_authors><pubmed_authors>Wu ZL</pubmed_authors><pubmed_authors>Li JY</pubmed_authors><pubmed_authors>Huang PL</pubmed_authors></additional><is_claimable>false</is_claimable><name>New &lt;i>ent&lt;/i>-kaurane diterpenoid acids from &lt;i>Nouelia insignis&lt;/i> Franch and their anti-inflammatory activity.</name><description>Eleven undescribed &lt;i>ent&lt;/i>-kaurane-type diterpenoid acids, namely noueinsiancins A-K (1-11), together with sixteen related known analogs (12-27) were isolated from &lt;i>Nouelia insignis&lt;/i> Franch. The chemical structures and absolute configurations of the new compounds were confirmed by the extensive spectroscopic data, electronic circular dichroism (ECD) data analysis and single crystal X-ray diffraction. Additionally, the anti-inflammatory assay was applied to estimate the nitric oxide (NO) inhibitory activities of all compounds by using lipopolysaccharide (LPS)-induced RAW 264.7 cells &lt;i>in vitro&lt;/i>. The results revealed that 4-7 and 13-17 significantly inhibited NO production at the concentrations of 2.5 μM, 5.0 μM and 10.0 μM. Meanwhile, compounds 6 and 7 were found to down-regulat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-04T23:16:38.246Z</modification><creation>2025-04-04T23:16:38.246Z</creation></dates><accession>S-EPMC8995843</accession><cross_references><pubmed>35425047</pubmed><doi>10.1039/d2ra01684b</doi></cross_references></HashMap>